| 8101 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2015 |
Standard Therapy |
Germany |
70 |
| 8102 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2015 |
Standard Therapy |
Germany |
71 |
| 8103 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2015 |
Standard Therapy |
Germany |
62 |
| 8104 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2015 |
Standard Therapy |
Germany |
56 |
| 8105 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2015 |
Standard Therapy |
Germany |
74 |
| 8106 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2015 |
Standard Therapy |
Germany |
50 |
| 8107 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2015 |
Standard Therapy |
Germany |
51 |
| 8108 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2015 |
Standard Therapy |
Germany |
63 |
| 8109 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2015 |
Standard Therapy |
Germany |
53 |
| 8110 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2015 |
Standard Therapy |
Germany |
72 |
| 8111 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2015 |
Standard Therapy |
Germany |
48 |
| 8112 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2015 |
Standard Therapy |
Germany |
63 |
| 8113 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2015 |
Standard Therapy |
Germany |
60 |
| 8114 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2015 |
Standard Therapy |
Germany |
65 |
| 8115 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2015 |
Standard Therapy |
Germany |
71 |
| 8116 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2015 |
Standard Therapy |
Germany |
61 |
| 8117 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2015 |
Standard Therapy |
Germany |
61 |
| 8118 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2015 |
Standard Therapy |
Germany |
61 |
| 8119 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2015 |
Standard Therapy |
Germany |
64 |
| 8120 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2015 |
Standard Therapy |
Germany |
48 |
| 8121 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2015 |
Standard Therapy |
Germany |
49 |
| 8122 |
Apheresis |
Allogeneic |
Multiple Myeloma, Second Acute Myeloid Leukemia |
Hematology |
2015 |
Standard Therapy |
Germany |
64 |
| 8123 |
Apheresis |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2015 |
Standard Therapy |
Germany |
57 |
| 8124 |
Apheresis |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2015 |
Standard Therapy |
Germany |
60 |
| 8125 |
Apheresis |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2015 |
Standard Therapy |
Germany |
29 |
| 8126 |
Apheresis |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2015 |
Standard Therapy |
Germany |
73 |
| 8127 |
Apheresis |
Allogeneic |
Non-Hodgkin Lymphoma |
Hematology |
2015 |
Standard Therapy |
Germany |
62 |
| 8128 |
Apheresis |
Allogeneic |
Non-Hodgkin Lymphoma |
Hematology |
2015 |
Standard Therapy |
Germany |
22 |
| 8129 |
Apheresis |
Autologous |
Non-Hodgkin Lymphoma |
Hematology |
2015 |
Standard Therapy |
Germany |
61 |
| 8130 |
Apheresis |
Allogeneic |
Post–Polycythemia Vera Myelofibrosis |
Hematology |
2015 |
Standard Therapy |
Germany |
54 |
| 8131 |
Apheresis |
Autologous |
Primary Central Nervous System Lymphoma |
Hematology |
2015 |
Standard Therapy |
Germany |
61 |
| 8132 |
Apheresis |
Autologous |
Primary Central Nervous System Lymphoma |
Hematology |
2015 |
Standard Therapy |
Germany |
41 |
| 8133 |
Apheresis |
Autologous |
Primary Central Nervous System Lymphoma |
Hematology |
2015 |
Standard Therapy |
Germany |
70 |
| 8134 |
Apheresis |
Allogeneic |
Primary Myelofibrosis |
Hematology |
2015 |
Standard Therapy |
Germany |
70 |
| 8135 |
Apheresis |
Allogeneic |
T-Cell Non-Hodgkin Lymphoma |
Hematology |
2015 |
Standard Therapy |
Germany |
44 |
| 8136 |
Cord Tissue |
Allogeneic – Unrelated |
Acute Graft Versus Host Disease |
Hematology |
2014 |
Experimental Therapy |
Poland |
6 |
| 8137 |
Cord Tissue |
Allogeneic – Unrelated |
Amyotrophic Lateral Sclerosis |
Neurology |
2014 |
Experimental Therapy |
Poland |
60,1 |
| 8138 |
Cord Tissue |
Allogeneic – Unrelated |
Amyotrophic Lateral Sclerosis |
Neurology |
2014 |
Experimental Therapy |
Poland |
24,1 |
| 8139 |
Cord Tissue |
Allogeneic – Unrelated |
Autism |
Neurology |
2014 |
Experimental Therapy |
Poland |
12,6 |
| 8140 |
Cord Tissue |
Allogeneic – Unrelated |
Autism |
Neurology |
2014 |
Experimental Therapy |
Poland |
8,3 |
| 8141 |
Cord Tissue |
Allogeneic – Unrelated |
Birth Asphyxia; Retinopathy |
Neurology |
2014 |
Experimental Therapy |
Poland |
11 months |
| 8142 |
Cord Tissue |
Allogeneic – Unrelated |
Central Motor Coordination Impairment After Hypoxic Ischemic Lesion At Birth |
Neurology |
2014 |
Experimental Therapy |
Poland |
2,1 |
| 8143 |
Cord Tissue |
Allogeneic – Unrelated |
Cerebral Palsy |
Neurology |
2014 |
Experimental Therapy |
Poland |
4,1 |
| 8144 |
Cord Tissue |
Allogeneic – Unrelated |
Cerebral Palsy |
Neurology |
2014 |
Experimental Therapy |
Poland |
15,1 |
| 8145 |
Cord Tissue |
Allogeneic – Unrelated |
Muscular Dystrophy |
Neurology |
2014 |
Experimental Therapy |
Poland |
6 |
| 8146 |
Cord Tissue |
Allogeneic – Unrelated |
Neuropathy |
Neurology |
2014 |
Experimental Therapy |
Poland |
23,6 |
| 8147 |
Cord Blood |
Allogeneic – Unrelated |
Acute Lymphoblastic Leukemia |
Hematology |
2014 |
Standard Therapy |
Spain |
15 |
| 8148 |
Cord Blood |
Allogeneic – Related |
Acute Lymphoblastic Leukemia |
Hematology |
2014 |
Standard Therapy |
Turkey |
8,8 |
| 8149 |
Cord Blood |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2014 |
Standard Therapy |
Germany |
45 |
| 8150 |
Cord Blood |
Autologous |
Acute Myeloid Leukemia |
Hematology |
2014 |
Standard Therapy |
Portugal |
6 |
| 8151 |
Cord Blood |
Allogeneic – Related |
Beta Thalassemia |
Hematology |
2014 |
Standard Therapy |
Germany |
6 |
| 8152 |
Cord Blood |
Autologous |
Cerebral Palsy |
Neurology |
2014 |
Experimental Therapy |
Portugal |
4 |
| 8153 |
Cord Blood |
Autologous |
Cerebral Palsy |
Neurology |
2014 |
Experimental Therapy |
UK |
1 |
| 8154 |
Cord Blood |
Autologous |
Hsv Encephalitis And Nmda Receptor Antibody Encephalitis |
Neurology |
2014 |
Experimental Therapy |
UK |
2 |
| 8155 |
Cord Blood |
Autologous |
Hypoxia-Ischemic Encephalopathy (Hie) |
Neurology |
2014 |
Experimental Therapy |
UK |
3 months |
| 8156 |
Cord Blood |
Allogeneic – Related |
Leukemia |
Hematology |
2014 |
Standard Therapy |
UK |
4 |
| 8157 |
Cord Blood |
Autologous |
Severe Aplastic Anemia |
Hematology |
2014 |
Standard Therapy |
Germany |
11 |
| 8158 |
Bone Marrow Family |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2014 |
Standard Therapy |
Germany |
35 |
| 8159 |
Bone Marrow Family |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2014 |
Standard Therapy |
Germany |
73 |
| 8160 |
Bone Marrow |
Allogeneic |
Non-Hodgkin-Lymphoma-Relapse |
Hematology |
2014 |
Standard Therapy |
Germany |
44 |
| 8161 |
Bone Marrow |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2014 |
Standard Therapy |
Germany |
60 |
| 8162 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2014 |
Standard Therapy |
Germany |
52 |
| 8163 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2014 |
Standard Therapy |
Germany |
69 |
| 8164 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2014 |
Standard Therapy |
Germany |
51 |
| 8165 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2014 |
Standard Therapy |
Germany |
69 |
| 8166 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2014 |
Standard Therapy |
Germany |
52 |
| 8167 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2014 |
Standard Therapy |
Germany |
29 |
| 8168 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2014 |
Standard Therapy |
Germany |
76 |
| 8169 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2014 |
Standard Therapy |
Germany |
48 |
| 8170 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2014 |
Standard Therapy |
Germany |
53 |
| 8171 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia – Relapse |
Hematology |
2014 |
Standard Therapy |
Germany |
45 |
| 8172 |
Apheresis |
Allogeneic |
Aplastic Anemia |
Hematology |
2014 |
Standard Therapy |
Germany |
27 |
| 8173 |
Apheresis |
Allogeneic |
Aplastic Anemia |
Hematology |
2014 |
Standard Therapy |
Germany |
44 |
| 8174 |
Apheresis |
Autologous |
B-Cell Non-Hodgkin Lymphoma |
Hematology |
2014 |
Standard Therapy |
Germany |
46 |
| 8175 |
Apheresis |
Autologous |
B-Cell Non-Hodgkin Lymphoma – Relapse |
Hematology |
2014 |
Standard Therapy |
Germany |
67 |
| 8176 |
Apheresis |
Autologous |
Bing–Neel Syndrome; Lymphoma |
Hematology |
2014 |
Standard Therapy |
Germany |
64 |
| 8177 |
Apheresis |
Allogeneic |
Chronic Lymphocytic Leukemia |
Hematology |
2014 |
Standard Therapy |
Germany |
42 |
| 8178 |
Apheresis |
Allogeneic |
Chronic Myelogenous Leukemia |
Hematology |
2014 |
Standard Therapy |
Germany |
57 |
| 8179 |
Apheresis |
Allogeneic |
Composite Lymphoma |
Hematology |
2014 |
Standard Therapy |
Germany |
59 |
| 8180 |
Apheresis |
Autologous |
Diffuse Large B-Cell Lymphoma |
Hematology |
2014 |
Standard Therapy |
Germany |
53 |
| 8181 |
Apheresis |
Autologous |
Diffuse Large B-Cell Lymphoma |
Hematology |
2014 |
Standard Therapy |
Germany |
50 |
| 8182 |
Apheresis |
Autologous |
Diffuse Large B-Cell Lymphoma |
Hematology |
2014 |
Standard Therapy |
Germany |
63 |
| 8183 |
Apheresis |
Autologous |
Germ Cell Tumor |
Hematology |
2014 |
Standard Therapy |
Germany |
24 |
| 8184 |
Apheresis |
Autologous |
Lymphoma-Relapse |
Hematology |
2014 |
Standard Therapy |
Germany |
56 |
| 8185 |
Apheresis |
Autologous |
Mantle Cell Lymphoma |
Hematology |
2014 |
Standard Therapy |
Germany |
51 |
| 8186 |
Apheresis |
Autologous |
Mantle Cell Lymphoma |
Hematology |
2014 |
Standard Therapy |
Germany |
62 |
| 8187 |
Apheresis |
Autologous |
Mantle Cell Lymphoma |
Hematology |
2014 |
Standard Therapy |
Germany |
58 |
| 8188 |
Apheresis |
Autologous |
Mantle Cell Lymphoma |
Hematology |
2014 |
Standard Therapy |
Germany |
62 |
| 8189 |
Apheresis |
Autologous |
Mantle Cell Lymphoma |
Hematology |
2014 |
Standard Therapy |
Germany |
51 |
| 8190 |
Apheresis |
Autologous |
Mantle Cell Lymphoma |
Hematology |
2014 |
Standard Therapy |
Germany |
59 |
| 8191 |
Apheresis |
Autologous |
Mantle Cell Lymphoma |
Hematology |
2014 |
Standard Therapy |
Germany |
68 |
| 8192 |
Apheresis |
Allogeneic |
Mantle Cell Lymphoma |
Hematology |
2014 |
Standard Therapy |
Germany |
60 |
| 8193 |
Apheresis |
Autologous |
Marginal Zone Lymphoma |
Hematology |
2014 |
Standard Therapy |
Germany |
52 |
| 8194 |
Apheresis |
Allogeneic |
Morbus Hodgkin |
Hematology |
2014 |
Standard Therapy |
Germany |
31 |
| 8195 |
Apheresis |
Autologous |
Morbus Hodgkin-Relapse |
Hematology |
2014 |
Standard Therapy |
Germany |
44 |
| 8196 |
Apheresis |
Autologous |
Morbus Hodgkin-Relapse |
Hematology |
2014 |
Standard Therapy |
Germany |
37 |
| 8197 |
Apheresis |
Autologous |
Morbus Hodgkin-Relapse |
Hematology |
2014 |
Standard Therapy |
Germany |
19 |
| 8198 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2014 |
Standard Therapy |
Germany |
70 |
| 8199 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2014 |
Standard Therapy |
Germany |
71 |
| 8200 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2014 |
Standard Therapy |
Germany |
60 |